je.st
news
Valeant Profit Beats Estimates As U.S. Sales Stay Strong
2015-07-24 05:39:42| Biotech - Topix.net
Drugmaker Valeant Pharmaceuticals International Inc reported a better-than-expected quarterly profit, helped by strength in its dermatology business in the United States. The company also raised its earnings and revenue forecast for the year to reflect sales of recently acquired Salix Pharmaceuticals' irritable bowel syndrome drug, Xifaxan.
Tags: sales
stay
strong
profit
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||